KLF5 and prostate cancer: Deacetylation of KLF5 in prostate cancer cells stimulated inflammatory cancer-associated fibroblasts (iCAFs) through TNF-α to release FGF9, which in turn activated FGFR1 signaling in prostate cancer cells.